Blonanserin

Home > API & Intermediate > Inhibitors > Blonanserin Manufacturers > Blonanserin

Blonanserin

CAS NO.： 132810-10-7

FOB Price： NEGOTIABLE Get Latest Price

Specification： ≥99.5%

Documentation： Get COA after inquiry

Lead Time： 14-30 days

Max Capacity： -

Packing： 1KG/BOTTLE

Product Detail

Properties

English Name: Blonanserin

CAS No.: 132810-10-7

Molecular formula: C23H30FN3

Molecular weight: 367.5

Melting point: 117-119 ° C

Boiling point: 540.8 ± 50.0 ° C (predicted)

Density: 1.095 ± 0.06 g / cm3 (predicted)

Basic information: bunanserin is a new drug for the treatment of schizophrenia. Dopamine (d1-ii) and serotonin (htd2) receptors are highly selective antagonists of dopamine (d1-ii) α 1. H1 histamine receptor and M1 choline receptor have low affinity, high safety and less adverse reactions. They are mainly used in the treatment of atypical psychosis.

Properties

This product belongs to serotonin and dopamine antagonist (SDA). It is the second generation of atypical antipsychotic drugs. It has the blocking effect of dopamine D2 receptor equivalent to haloperidol, and also has a strong blocking effect on 5-HT2A. The selectivity of the two receptors is stronger than that of other antipsychotics. The side effects of extrapyramidal system are less than those of existing antipsychotics on the market. Developed and listed by Sumitomo Pharmaceutical Co., Ltd.

CAS No.

132810-10-7

Formula

C23H30FN3

Molecular Mass

367.5

Exact Mass

367.24200

PSA

19.37000

Logp

4.69150